MediciNova (MNOV) to Release Quarterly Earnings on Thursday

MediciNova (NASDAQ:MNOV - Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 20th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter.

MediciNova Trading Up 5.3 %

MNOV traded up $0.10 on Friday, reaching $1.97. The stock had a trading volume of 65,595 shares, compared to its average volume of 20,079. MediciNova has a 12-month low of $1.12 and a 12-month high of $2.55. The business's 50-day moving average price is $2.01 and its two-hundred day moving average price is $1.83. The company has a market cap of $96.63 million, a P/E ratio of -9.38 and a beta of 0.82.

Wall Street Analysts Forecast Growth

MNOV has been the subject of a number of recent analyst reports. D. Boral Capital started coverage on shares of MediciNova in a report on Monday, December 2nd. They issued a "buy" rating and a $9.00 price objective for the company. StockNews.com started coverage on shares of MediciNova in a research note on Tuesday, February 11th. They set a "hold" rating for the company.

About MediciNova

MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID.